Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin's Lymphoma - Relapsed/Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00644189
What this trial is testing

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

Who this might be right for
Follicular LymphomaMarginal Zone LymphomaMantle Cell Lymphoma+7 more
Massachusetts General Hospital 50
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT01344876
What this trial is testing

Phase I Study of OPB-51602 in Patients With Hematologic Malignancies

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaAcute Myeloid Leukemia+2 more
Otsuka Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05502250
What this trial is testing

Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission

Who this might be right for
Hodgkin Lymphoma
Stichting Hemato-Oncologie voor Volwassenen Nederland 75
Testing effectiveness (Phase 2)Study completedNCT00742027
What this trial is testing

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin's Lymphoma
Novartis Pharmaceuticals 129
Not applicableStudy completedNCT03860376
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+11 more
Florida International University 25
Early research (Phase 1)Study completedNCT00036946
What this trial is testing

VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Active Not RecruitingNCT03697408
What this trial is testing

Itacitinib + Everolimus in Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
University of Pennsylvania 23
Testing effectiveness (Phase 2)Study completedNCT01281917
What this trial is testing

Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
University of Wisconsin, Madison 40
Testing effectiveness (Phase 2)Study completedNCT03255018
What this trial is testing

Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas

Who this might be right for
Non-Hodgkin LymphomaLymphomaDiffuse Large B-Cell Lymphoma+2 more
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)Ended earlyNCT02703272
What this trial is testing

A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Janssen Research & Development, LLC 72
Testing effectiveness (Phase 2)Ended earlyNCT00265928
What this trial is testing

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Virginia 46
Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Looking for participantsNCT07022964
What this trial is testing

CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas

Who this might be right for
T-Cell Non-Hodgkin LymphomaT-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital 36
Testing effectiveness (Phase 2)UnknownNCT00002481
What this trial is testing

Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
St. Luke's Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03598998
What this trial is testing

Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas

Who this might be right for
Anaplastic Large Cell LymphomaNodal Peripheral T-Cell Lymphoma With TFH PhenotypeRecurrent Anaplastic Large Cell Lymphoma+17 more
City of Hope Medical Center 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04981899
What this trial is testing

Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
St. Petersburg State Pavlov Medical University 30
Early research (Phase 1)Temporarily pausedNCT00077493
What this trial is testing

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
MedImmune LLC 95
Next Page